St. Luke’s Cancer Institute improved oncology authorization by bringing clinical expertise directly into revenue cycle workflows. This collaboration helped reduce treatment delays, cut authorization turnaround time by more than 50%, decreased provider clarification requests by over 60%, and prevented nearly $100,000 in avoidable write-offs.
2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.